Target intelligence / Profile preview

VWA8 antisense RNA 1 (VWA8-AS1)

Target
VWA8-AS1
Molecular classification
Long non-coding RNA (lncRNA), Other (non-protein-coding RNA)
01

Overview

VWA8 antisense RNA 1 (VWA8-AS1) is a long non-coding RNA (lncRNA) of 2091 nucleotides, transcribed head-to-head relative to the VWA8 gene and not coding for protein. VWA8-AS1 is upregulated in certain cancers, notably in oral squamous cell carcinoma (OSCC) associated with Epstein–Barr virus (EBV) infection. Functional studies indicate that overexpression of VWA8-AS1 promotes cancer cell migration and invasion, implicating it in tumor progression and metastasis, while not significantly affecting cell proliferation. Bioinformatic analyses suggest it may act through interactions with multiple proteins (including important transcription factors and RNA-binding proteins), miRNAs, and participate in several regulatory pathways (e.g., p53, TGF-β, apoptosis, PI3K-AKT, MAPK, Hippo, and NF-κB pathways). It may also influence immune cell behavior in the tumor microenvironment. Dysregulated expression of VWA8-AS1 has been linked to gastric, thyroid, and kidney cancers and is being explored for its utility as a diagnostic marker or therapeutic target in EBV-associated cancers, though no drugs or targeted therapies against VWA8-AS1 are currently described[1][2].

Other names
VWA8 antisense RNA 1 (head to head)VWA8-AS1VWA8 antisense RNA 1 (non-protein coding)
02

Biological functions

Regulation of gene expressionChromatin modificationTranscription regulationRNA processingRNA splicingmiRNA sponge activityRegulation of cell migration and invasionImmune response modulation
03

Disease associations

Cancer (notably oral squamous cell carcinoma, gastric cancer, thyroid cancer, kidney cancers, others)Possibly testicular leukemiaAutoimmune/immune-related conditions such as polycystic ovary syndrome
04

Biomarkers

Potentially as a biomarker for Epstein–Barr virus (EBV)-associated oral squamous cell carcinoma and possibly for other cancers where overexpression is noted

Beyond the preview

Go deeper on VWA8 antisense RNA 1 (VWA8-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VWA8 antisense RNA 1 (VWA8-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call